I 

108TH CONGRESS 

2D SESSION H. R. 4812 

To require the National Institutes of Health to conduct and support research 

using human embryonic stem cells, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

JULY 12, 2004 

Mr. DEUTSCH introduced the following bill; which was referred to the 

Committee on Energy and Commerce 

A BILL 

To require the National Institutes of Health to conduct and 

support research using human embryonic stem cells, and 

for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Stem Cell Discovery 

5 Through Diversity Act’’. 

6 SEC. 2. STEM CELL RESEARCH; REQUIREMENT REGARDING 

7 RELATION TO INFERTILITY TREATMENT; DI8 VERSITY IN STEM CELLS. 

9 (a) IN GENERAL.—The Director of the National In10 stitutes of Health (referred to in this Act as the ‘‘Director 
2 

•HR 4812 IH 

1 of NIH’’), acting through the national research institutes, 

2 shall in accordance with this section conduct and support 

3 research using human embryonic stem cells. 

4 (b) APPLICABILITY OF 2000 NIH FINAL GUIDE5 LINES.— 

6 (1) IN GENERAL.—The Director of NIH shall 

7 ensure that research under subsection (a) is con8 ducted and supported in accordance with the final 

9 guidelines regarding such research that were issued 

10 by the National Institutes of Health and published 

11 in the Federal Register on August 25, 2000 (65 FR 

12 51976 et seq.), including— 

13 (A) the requirement that human embryonic 

14 stem cells used in the research be derived from 

15 human embryos that were created in vitro for 

16 purposes of fertility treatment and were in ex17 cess of the clinical need of the individuals seek18 ing such treatment; 

19 (B) the requirement that individuals seek20 ing such treatment voluntarily donated such 

21 embryos through a process of informed consent; 

22 and 

23 (C) the prohibition that Federal funds may 

24 not be used for the derivation of such cells from 

25 the embryos. 
3 

•HR 4812 IH 

1 (2) CERTAIN RESTRICTIONS.—Restrictions on 

2 research described in subsection (a) established for 

3 the Department of Health and Human Services pur4 suant to policies announced by the President on Au5 gust 9, 2001, have no legal effect on or after the 

6 date of the enactment of this Act. 

7 (3) ADDITIONAL ADMINISTRATIVE POLICES.— 

8 With respect to research under subsection (a), Fed9 eral administrative policies in addition to the guide10 lines under paragraph (1) may not be established or 

11 applied. 

12 (c) DIVERSITY IN SOURCES OF STEM CELLS.—With 

13 respect to donations referred to in subsection (b)(1)(B) 

14 (relating to sources of human embryonic stem cells), the 

15 Director of NIH shall ensure that the program under sub16 section (a) includes donations from a significant number 

17 of individuals who are members of racial or ethnic minor18 ity groups in order to make progress toward the goal (con19 sistent with principles underlying the requirement under 

20 section 492B of the Public Health Service Act that such 

21 individuals be included as subjects in research) of devel22 oping an understanding of whether the variables studied 

23 in clinical research affect such individuals differently than 

24 the general population. 
4 

•HR 4812 IH 

1 (d) REPORT TO CONGRESS.—The Director of NIH 

2 shall annually submit to the Congress a report on the pro3 gram of research carried out under subsection (a). The 

4 report shall include a description of the actions taken by 

5 the Director to comply with subsection (c) and a deter6 mination by the Director of the progress being made to7 ward the goal described in such subsection. 

8 SEC. 3. RONALD REAGAN OFFICE OF HUMAN STEM CELL 

9 RESEARCH. 

10 The Director of NIH shall establish within the office 

11 of the Director an office to be known as the Ronald 

12 Reagan Office of Human Stem Cell Research, which shall 

13 be headed by a director appointed by the Director of NIH. 

14 The Office shall coordinate all research conducted or sup15 ported by the National Institutes of Health that uses 

16 human pluripotent stem cells. 

Æ